Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 1;79(4):E113-E114.
doi: 10.1097/HEP.0000000000000689. Epub 2023 Nov 16.

Reply: Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome-First report of the IAIHG retrospective registry

Affiliations

Reply: Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome-First report of the IAIHG retrospective registry

Charlotte D Slooter et al. Hepatology. .
No abstract available

PubMed Disclaimer

References

    1. He S, Peng Y, Wei Q. Letter to the editor: Identifying prognostic factors for adverse liver-related outcomes based on the IAIHG-RR cohort. Hepatology. 2023. doi:10.1097/HEP.0000000000000685. Epub ahead of print.
    1. Slooter CD, van den Brand FF, Lleo A, Colapietro F, Lenzi M, Muratori P, et al. Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry. Hepatology. 2024;79:538–550.
    1. Laschtowitz A, Zachou K, Lygoura V, Pape S, Derben F, Jaeckel E, et al. Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis. JHEP Rep. 2021;3:100321.
    1. Dhaliwal HK, Hoeroldt BS, Dube AK, McFarlane E, Underwood JCE, Karajeh MA, et al. Long-term prognostic significance of persisting histological activity despite biochemical remission in autoimmune hepatitis. Am J Gastroenterol. 2015;110:993–999.
    1. Weismüller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, et al. Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology. 2017;152:1975–84.e8.

LinkOut - more resources